Robert E. Notari

1.7k total citations
66 papers, 1.4k citations indexed

About

Robert E. Notari is a scholar working on Molecular Biology, Organic Chemistry and Spectroscopy. According to data from OpenAlex, Robert E. Notari has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Organic Chemistry and 15 papers in Spectroscopy. Recurrent topics in Robert E. Notari's work include Analytical Chemistry and Chromatography (13 papers), Pharmaceutical studies and practices (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Robert E. Notari is often cited by papers focused on Analytical Chemistry and Chromatography (13 papers), Pharmaceutical studies and practices (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Robert E. Notari collaborates with scholars based in United States, United Kingdom and Egypt. Robert E. Notari's co-authors include J.‐L. M. Abboud, Richard H. Reuning, Peter R. Byron, Richard A. Sams, Mingxing Zhou, James W. Munson, Allan M. Burkman, Eric Tomlinson, Dan Wang and Edward R. Garrett and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Robert E. Notari

65 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Notari United States 19 349 281 249 186 159 66 1.4k
H.B. Kostenbauder United States 21 283 0.8× 310 1.1× 153 0.6× 267 1.4× 145 0.9× 78 1.2k
Douglas E. Moore Australia 29 459 1.3× 321 1.1× 336 1.3× 208 1.1× 237 1.5× 74 2.1k
Gerald J. Yakatan United States 16 178 0.5× 169 0.6× 151 0.6× 176 0.9× 179 1.1× 50 997
David E. Guttman United States 16 370 1.1× 148 0.5× 154 0.6× 290 1.6× 148 0.9× 36 945
Lewis W. Dittert United States 24 420 1.2× 216 0.8× 386 1.6× 263 1.4× 209 1.3× 81 2.0k
Joachim K. Seydel Germany 25 917 2.6× 650 2.3× 216 0.9× 316 1.7× 129 0.8× 112 2.2k
Theodore R. Bates United States 22 226 0.6× 130 0.5× 184 0.7× 188 1.0× 209 1.3× 53 1.4k
J.H. Perrin United States 25 1.0k 2.9× 242 0.9× 297 1.2× 677 3.6× 301 1.9× 128 2.1k
Richard J. Prankerd Australia 21 392 1.1× 312 1.1× 143 0.6× 134 0.7× 62 0.4× 67 1.3k
John L. Lach United States 23 303 0.9× 255 0.9× 109 0.4× 425 2.3× 272 1.7× 68 1.5k

Countries citing papers authored by Robert E. Notari

Since Specialization
Citations

This map shows the geographic impact of Robert E. Notari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Notari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Notari more than expected).

Fields of papers citing papers by Robert E. Notari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Notari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Notari. The network helps show where Robert E. Notari may publish in the future.

Co-authorship network of co-authors of Robert E. Notari

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Notari. A scholar is included among the top collaborators of Robert E. Notari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Notari. Robert E. Notari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Notari, Robert E.. (2017). Biopharmaceutics and Clinical Pharmacokinetics. 3 indexed citations
2.
Notari, Robert E., et al.. (1999). A Nomogram to Evaluate Intrinsic Absorption Rate Constants of Potential Oral Prolonged-Release Candidates. Pharmaceutical Development and Technology. 4(3). 305–312. 1 indexed citations
3.
Abboud, J.‐L. M. & Robert E. Notari. (1999). Critical compilation of scales of solvent parameters. Part I. Pure, non-hydrogen bond donor solvents. Pure and Applied Chemistry. 71(4). 645–718. 343 indexed citations
4.
Notari, Robert E., et al.. (1998). Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions. Journal of Pharmaceutical Sciences. 87(12). 1572–1576. 41 indexed citations
5.
Notari, Robert E., et al.. (1998). A Kinetic Oxymoron: Concentration-Dependent First-Order Rate Constants for Hydrolysis of Ceftazidime. Journal of Pharmaceutical Sciences. 87(1). 53–58. 19 indexed citations
6.
Zhou, Mingxing & Robert E. Notari. (1996). A Nomogram To Predict the Best Biological Half-Life Values for Candidates for Oral Prolonged-Release Formulations. Journal of Pharmaceutical Sciences. 85(8). 791–795. 5 indexed citations
7.
Zhou, Mingxing & Robert E. Notari. (1995). Influence of pH, Temperature, and Buffers on the Kinetics of Ceftazidime Degradation in Aqueous Solutions. Journal of Pharmaceutical Sciences. 84(5). 534–538. 41 indexed citations
8.
Lam, Chan F., et al.. (1993). An efficient method for computer-aided dosage form design. Computers in Biology and Medicine. 23(6). 475–482. 2 indexed citations
9.
Notari, Robert E., et al.. (1991). Computer-Aided Dosage Form Design. III. Feasibility Assessment for an Oral Prolonged-Release Phenytoin Product. Pharmaceutical Research. 8(2). 232–237. 4 indexed citations
10.
Notari, Robert E., et al.. (1989). Substituent Effects on Degradation Rates and Pathways of Cytosine Nucleosides. Journal of Pharmaceutical Sciences. 78(10). 802–806. 4 indexed citations
11.
12.
Notari, Robert E., et al.. (1988). Predicting Caffeine Plasma Concentrations Resulting from Consumption of Food or Beverages: A Simple Method and its Origin. Drug Intelligence & Clinical Pharmacy. 22(12). 953–959. 18 indexed citations
13.
Notari, Robert E., et al.. (1988). Potential Improvement in Shelf Life Using the Prodrug Approach. II. A Systematic Examination of Kinetic Requirements. Pharmaceutical Research. 5(10). 634–638. 1 indexed citations
14.
Notari, Robert E., et al.. (1987). Computer-Aided Dosage Form Design. I. Methods for Defining a Long-Acting First-Order Delivery System of Maximum Formulating Flexibility. Pharmaceutical Research. 4(4). 311–316. 6 indexed citations
15.
Notari, Robert E., et al.. (1987). Kinetics and Mechanism of Captopril Oxidation in Aqueous Solution Under Controlled Oxygen Partial Pressure. Pharmaceutical Research. 4(2). 98–103. 22 indexed citations
16.
Notari, Robert E., et al.. (1987). Computer-Aided Dosage Form Design. II. Methods for Defining a Zero-Order Sustained-Release Delivery System of Maximum Formulating Flexibility. Pharmaceutical Research. 4(5). 385–391. 5 indexed citations
17.
Notari, Robert E., et al.. (1974). Apparent biological half-life values determined by administration of drug by methods other than rapid intravenous injection. Journal of Pharmacy and Pharmacology. 26(Supplement_1). 62P–63P. 1 indexed citations
18.
Notari, Robert E.. (1971). Biopharmaceutics and pharmacokinetics;: An introduction. Medical Entomology and Zoology. 79 indexed citations
19.
Notari, Robert E., et al.. (1969). Catalysis of Streptovitacin A Dehydration: Kinetics and Mechanisms. Journal of Pharmaceutical Sciences. 58(10). 1203–1208. 10 indexed citations
20.
Notari, Robert E. & Theodore D. Sokoloski. (1965). Kinetics of Calcium Carbonate Neutralization. Journal of Pharmaceutical Sciences. 54(10). 1500–1504. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.B. Kostenbauder Breakdown of academic impact, for papers by Douglas E. Moore Breakdown of academic impact, for papers by Gerald J. Yakatan Breakdown of academic impact, for papers by David E. Guttman Breakdown of academic impact, for papers by Lewis W. Dittert Breakdown of academic impact, for papers by Joachim K. Seydel Breakdown of academic impact, for papers by Theodore R. Bates Breakdown of academic impact, for papers by J.H. Perrin Breakdown of academic impact, for papers by Richard J. Prankerd Breakdown of academic impact, for papers by John L. Lach
Rankless by CCL
2026